Susquehanna International Group
SPRY icon

Susquehanna International Group’s ARS Pharmaceuticals SPRY Stock Holding History

Susquehanna International Group’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409K Sell
50,900
-175,900
-78% -$1.69M ﹤0.01% 10157
2025
Q4 		$2.64M Sell
226,800
-33,500
-13% -$326K ﹤0.01% 5105
2025
Q3 		$2.62M Buy
260,300
+201,200
+340% +$2.89M ﹤0.01% 5233
2025
Q2 		$1.03M Buy
59,100
+1,200
+2% +$17.3K ﹤0.01% 7358
2025
Q1 		$728K Sell
57,900
-27,400
-32% -$330K ﹤0.01% 8049
2024
Q4 		$900K Sell
85,300
-162,400
-66% -$2.27M ﹤0.01% 7222
2024
Q3 		$3.59M Buy
247,700
+214,100
+637% +$2.55M ﹤0.01% 4215
2024
Q2 		$286K Buy
+33,600
New +$298K ﹤0.01% 9563
2024
Q1 		– Sell
-173,800
Closed -$952K – 13269
2023
Q4 		$952K Sell
173,800
-64,700
-27% -$283K ﹤0.01% 7105
2023
Q3 		$902K Buy
238,500
+206,000
+634% +$1.35M ﹤0.01% 6863
2023
Q2 		$218K Buy
32,500
+18,500
+132% +$123K ﹤0.01% 10117
2023
Q1 		$91.1K Buy
+14,000
New +$108K ﹤0.01% 11364
2022
Q4 		– Sell
-107,800
Closed -$569K – 13607
2022
Q3 		$569K Sell
107,800
-247,000
-70% -$1.22M ﹤0.01% 8148
2022
Q2 		$1.5M Buy
+354,800
New +$1.24M ﹤0.01% 5531
2021
Q4 		– Sell
-13,600
Closed -$136K – 13867
2021
Q3 		$136K Buy
+13,600
New +$335K ﹤0.01% 11864

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Susquehanna International Group's SPRY Position: Q1 2026 in Review

Susquehanna International Group opened a new position in ARS Pharmaceuticals (SPRY) in Q1 2026: 60,537 shares worth $486K. The stake represents ﹤0.01% of the portfolio and ranks #9747 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in SPRY as recently as Q2 2025.

Susquehanna International Group first reported a position in SPRY in Q2 2022 and has held it in 13 quarters since. The position peaked at $4.48M in Q2 2025. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • Susquehanna International Group held 60,537 shares of ARS Pharmaceuticals worth $486K as of Q1 2026.
  • ARS Pharmaceuticals was a new Susquehanna International Group position in Q1 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9747 holding.
  • Susquehanna International Group first reported a position in ARS Pharmaceuticals in Q2 2022 and has held it in 13 quarters since.
  • Susquehanna International Group's ARS Pharmaceuticals position peaked at $4.48M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.